Can anti-cyclic citrullinated peptide antibody-negative RA be subdivided into clinical subphenotypes?
The current data provide evidence that, for risk-factor studies, anti-CCP-negative RA patients can be studied as one group.
Elevated cord blood IMA levels may be accepted as a useful marker in perinatal asphyxia. Abnormal Doppler examinations are associated with elevated IMA levels in complicated pregnancies.